Author: Restem

Posted Date:

February 23, 2026

RESTEM to Present at BIO Investment & Growth Summit 2026

Restem

February 23, 2026
RESTEM Announces First Patient Dosed in the Phase 2/3 IIMPACT Study of Restem-L in Idiopathic Inflammatory Myopathy

Restem

February 3, 2026